{"disease":{"id":"stargardt-s-disease","name":"Stargardt's disease","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":1},"drugs":{"marketed":[{"drug_id":"echothiophate","indication_name":"Stargardt's disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Phospholine Iodide","generic_name":"ECHOTHIOPHATE","company_name":"Fera Pharms Llc","drug_phase":"marketed","molecular_target":"Acetylcholinesterase","drug_class":"Cholinesterase Inhibitor","quality_score":35,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02617966","title":"Rod and Cone Mediated Function in Retinal Disease","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT06375239","title":"Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Ray Therapeutics, Inc.","has_results":false},{"nct_id":"NCT06445322","title":"Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Ascidian Therapeutics, Inc","has_results":false},{"nct_id":"NCT05258032","title":"Structural and Functional Characterization of Rare Ocular Diseases","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Barcelona Macula Foundation","has_results":false},{"nct_id":"NCT01736592","title":"Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt's Macular Degeneration","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":27,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT01367444","title":"Phase I/IIA Study of SAR422459 in Participants With Stargardt's Macular Degeneration","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":27,"lead_sponsor_name":"Sanofi","has_results":true},{"nct_id":"NCT04281732","title":"Visual Performance Measures in a Virtual Reality Environment for Assessing Clinical Trial Outcomes in Those With Severely Reduced Vision","phase":"","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Queen's University, Belfast","has_results":false},{"nct_id":"NCT05674058","title":"Function and Imaging Assessments for G1961E-associated Stargardt Disease","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":20,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT06467344","title":"Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"Ascidian Therapeutics, Inc","has_results":false},{"nct_id":"NCT00420602","title":"DHA Supplementation in Patients With STGD3","phase":"NA","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"University of Utah","has_results":false}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}